Express Scripts, Inc. (ESRX)
$85.22
0.72 (+0.85%)
| CAPS Rating |
|
|---|---|
| Open | $85.34 |
| Previous Close | $84.50 |
| Daily Range | $84.22 - $86.12 |
| 52-Week Range | $42.75 - $93.00 |
| Market Cap | $23.41B |
| P/E Ratio | 26.83 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,115,877 |
| Average Daily Volume | 0 |
ESRX
VS S&P 500 (SPY)
How do you think ESRX will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ESRX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ESRX News and Commentary
- Surfing the Wave of the Future: Personalized Medicine – The Motley Fool
- Is Your 401(k) Failing You? – The Motley Fool
- UPDATE: Drug Benefit Managers Targeted For More US Oversight – SmartMoney
- Drug Benefit Managers Targeted For More Oversight In US Bill – SmartMoney
- One Stock to Buy Today? – The Motley Fool
- Health Care Stocks Need Quite A Surge To Meet Latest Analyst Targets – SmartMoney
- America's Next Top Growth Stock – The Motley Fool
- Insurance is the opiate of the people. – Blog at The Motley Fool
- Walgreen Lives to Fight Another Day – The Motley Fool
- The Next Home Run Stock – The Motley Fool
- Buy This Investment If You Want to Lose Money – The Motley Fool
- UPDATE 1-Express Scripts closes WellPoint drug unit deal – Reuters
- Time to Sell Those Winners -- and Losers – The Motley Fool
- CVS Caremark CEO:Company Fixing Drug-Benefit Business Problems – SmartMoney
- CVS Caremark Aims To Fix Pharmacy Benefit Marketing Message – SmartMoney
- This One Is Thriving in a Recession – The Motley Fool
- What Will You Regret Not Buying in 20 Years? – The Motley Fool
- WHOOP There It Is! HR3962 – Blog at The Motley Fool
- Staggering w/sugar shock from the KoolAid.....?? – Blog at The Motley Fool
- Expressing Itself Nicely – The Motley Fool
RSS Headlines
Fool UK
